References
- Ito C, Hayashi Y, Asaoka T, Ohinishi H, Yayima G. Toxicological studies of miconazole (V). Chronic toxicity study of miconazole in dogs. Iyakuhin Kenkyu 1978; 7: 518.
- Bononi LJ, Principe L, Spignoli G. Sulfosalicylate salts of econazole and miconazole: experimental and clinical evaluation. J Drug Dev 1990; 2: 221–226.
- Strippoli V, D’Auria FD, Simonetti N. In vitro antimicrobial activity of econazole and miconazole sulfosalicylate. Drugs Exptl Clin Res 1990; 16,5: 237–242.
- D’Auria FD, Villa A, Simonetti N. Action of miconazole at high concentration against Candida albicans. J Chemother 1989; 1, 4: 240–248.
- Cope JE. Mode of action of miconazole on Candida albicans: effect on growth, viability and K+ release. J Gen Microbiol 1980; 119: 245–251.
- Kerridge D. Mode of action of clinically important antifungal drugs. Adv Microb Phys 1986; 27: 1–72.
- Goodman and Gilman’s. The Pharmacological Basis of Therapeutics. 6th Ed. New York: McMillan Pubi Co Inc.1980: 693.
- Sud IJ, Feingold DS. Mechanism of action of the antimycotic imidazole. J Invest Dermatol 1981; 76: 438–441.
- Villa AS, Simonetti N, D’Auria FD. Vaginal azole drug. Proc Eur Soc Infect Dis Obst Gynecology. II Int Meeting, Gardone Riviera, May 3-7, Bologna: Monduzzi 1990; 201–209.